Takeda: European Commission Grants Marketing Authorization For Dengue Vaccine, QDENGA

TOKYO (dpa-AFX) - Takeda (TAK) announced the European Commission granted marketing authorization for the company's dengue vaccine QDENGA for the prevention of dengue disease in individuals from

Related Keywords

Tokyo ,Japan , ,European Union ,European Commission ,European Medicines Agency ,More Such Health News ,Takeda ,European ,Commission ,Migrants ,Marketing ,Authorization ,Dengue ,Vaccine ,Udenga ,